{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:32:07Z","timestamp":1761154327722},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1053\/berh.2000.0087","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"445-460","source":"Crossref","is-referenced-by-count":37,"title":["Gout and other crystal-associated arthropathies"],"prefix":"10.1053","volume":"14","author":[{"given":"Neil W.","family":"McGill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/berh.2000.0087_RF1","first-page":"395","article-title":"Serum uric acid levels and gout: what does this herald for the population?","volume":"12","author":"Rigby","year":"1994","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002560050477","article-title":"Intra-articular gouty tophi of the knee: CT and MR imaging in 12 patients","volume":"28","author":"Chen","year":"1999","journal-title":"Skeletal Radiology"},{"key":"10.1053\/berh.2000.0087_RF3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/ard.58.5.261","article-title":"Identification of crystals in synovial fluid","volume":"58","author":"Dieppe","year":"1999","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ard.56.8.504","article-title":"Quality assurance for synovial fluid examination for crystals: an improved method","volume":"65","author":"McGill","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the normative aging study","volume":"82","author":"Campion","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2000.0087_RF6","first-page":"2265","article-title":"Serum uric acid during bouts of acute gouty arthritis","volume":"24","author":"Schlesinger","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.56.11.696a","article-title":"Serum uric acid in acute gout","volume":"56","author":"Logan","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1023\/A:1005308923168","article-title":"When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications","volume":"29","author":"Simmonds","year":"1997","journal-title":"Journal of Inherited and Metabolic Diseases"},{"key":"10.1053\/berh.2000.0087_RF9","series-title":"Textbook of Rheumatology","first-page":"1313","article-title":"Gout and hyperuricemia","author":"Kelley","year":"1997"},{"key":"10.1053\/berh.2000.0087_RF10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.jhh.1000496","article-title":"Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up","volume":"11","author":"Grodzicki","year":"1997","journal-title":"Journal of Human Hypertension"},{"key":"10.1053\/berh.2000.0087_RF11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.57.9.509","article-title":"Hyperlipidaemia in hyperuricaemia and gout","volume":"57","author":"Emmerson","year":"1998","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0272-6386(99)70295-7","article-title":"Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease","volume":"33","author":"Johnson","year":"1999","journal-title":"American Journal of Kidney Disease"},{"key":"10.1053\/berh.2000.0087_RF13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","article-title":"Gout and risk for subsequent coronary heart disease. The Meharry\u2013Hopkins Study","volume":"157","author":"Gelber","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/berh.2000.0087_RF14","series-title":"Gout, Hyperuricemia, and Other Crystal-Associated Arthropathies","first-page":"241","article-title":"Gout and renal disease","author":"Emmerson","year":"1999"},{"key":"10.1053\/berh.2000.0087_RF15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000046298","article-title":"Hyperuricemic nephropathies","volume":"81","author":"Steele","year":"1999","journal-title":"Nephron"},{"key":"10.1053\/berh.2000.0087_RF16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0002-9343(79)90076-7","article-title":"Renal outcomes of gout and hyperuricemia","volume":"67","author":"Fessel","year":"1979","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2000.0087_RF17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.41.1.59","article-title":"Allopurinol treatment and its effect on renal function in gout: a controlled study","volume":"41","author":"Gibson","year":"1982","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF18","first-page":"494","article-title":"Does renal impairment protect from gout?","volume":"22","author":"Youssef","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1053\/berh.2000.0087_RF20","first-page":"495","article-title":"Review: systemic toxicity associated with the intravenous administration of colchicine \u2013 guidelines for use","volume":"15","author":"Wallace","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotrophic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0087_RF22","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF23","first-page":"1325","article-title":"Comparison of adrenocorticotrophic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis","volume":"21","author":"Siegel","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF24","first-page":"248","article-title":"Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal anti-inflammatory drugs","volume":"63","author":"Werlen","year":"1996","journal-title":"Revue du Rhumatisme"},{"key":"10.1053\/berh.2000.0087_RF25","first-page":"255","article-title":"Diversity of opinions on the management of gout in France","volume":"63","author":"Rozenberg","year":"1996","journal-title":"Revue Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/ard.58.10.611","article-title":"Gout","volume":"58","author":"Perkins","year":"1999","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF27","first-page":"1383","article-title":"Withdrawal of longterm antihyperuricemic therapy in tophaceous gout","volume":"20","author":"van Lieshout-Zuidema","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF28","first-page":"S95","article-title":"Patient compliance in gout and polymyalgia rheumatica explored with an electronic monitoring device","volume":"42","author":"de Klerk","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0087_RF29","first-page":"1618","article-title":"An evidence-based appraisal of the management of nontophaceous interval gout","volume":"22","author":"Ferraz","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout","volume":"334","author":"Emmerson","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/berh.2000.0087_RF31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-5381-6_3","article-title":"Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment","volume":"431","author":"Yamanaka","year":"1998","journal-title":"Advances in Experimental and Medical Biology"},{"key":"10.1053\/berh.2000.0087_RF32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment: an open, randomised, actively controlled study","volume":"5","author":"Perez-Ruiz","year":"1999","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF34","first-page":"S172","article-title":"Influence of urate-lowering therapy on the rapidity of resolution of tophi in chronic gout","volume":"42","author":"Perez-Ruiz","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0087_RF35","first-page":"S173","article-title":"The effect of low dose aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis","volume":"42","author":"Danaher","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.2000.0087_RF36","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0041-1345(98)02031-4","article-title":"The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine","volume":"31","author":"Braun","year":"1999","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/berh.2000.0087_RF37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/9.5.548","article-title":"Excellent uricosuric efficacy of benzbromarone in cyclosporin A treated renal transplant patients: a prospective study","volume":"9","author":"Zurcher","year":"1994","journal-title":"Nephrology, Dialysis and Transplantation"},{"key":"10.1053\/berh.2000.0087_RF38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00007890-199710150-00027","article-title":"Safety of the mycophenolate mofetil\u2013allopurinol combination in kidney transplant recipients with gout","volume":"64","author":"Jacobs","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/berh.2000.0087_RF39","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/archopht.116.12.1652","article-title":"Exposure to allopurinol and the risk of cataract extraction in elderly patients","volume":"116","author":"Garbe","year":"1998","journal-title":"Archives of Ophthalmology"},{"key":"10.1053\/berh.2000.0087_RF40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(92)90236-5","article-title":"Desensitisation to allopurinol in patients with gout and cutaneous reactions","volume":"93","author":"Fam","year":"1992","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2000.0087_RF41","first-page":"392","article-title":"Urate oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases","volume":"62","author":"Rozenberg","year":"1995","journal-title":"Revue du Rhumatisme"},{"key":"10.1053\/berh.2000.0087_RF42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.58.9.582","article-title":"Most calcium pyrophosphate crystals appear as non-birefringent","volume":"58","author":"Ivorra","year":"1999","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0889-857X(05)70066-1","article-title":"The role of crystals in osteoarthritis","volume":"25","author":"Ryan","year":"1999","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/berh.2000.0087_RF44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00002281-199909000-00019","article-title":"What is the relation between crystals and osteoarthritis?","volume":"11","author":"Concoff","year":"1999","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1053\/berh.2000.0087_RF45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0899-7071(98)00029-1","article-title":"Prevalence and patterns of tendon calcification in patients with chondrocalcinosis of the knee: radiologic study of 156 patients","volume":"22","author":"Pereira","year":"1998","journal-title":"Clinical Imaging"},{"key":"10.1053\/berh.2000.0087_RF46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002560050400","article-title":"Chondrocalcinosis of the hyaline cartilage of the knee: MRI manifestations","volume":"27","author":"Beltran","year":"1998","journal-title":"Skeletal Radiology"},{"key":"10.1053\/berh.2000.0087_RF47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard.55.1.30","article-title":"Analysis of the association between chondrocalcinosis and osteoarthritis: a community based study","volume":"55","author":"Sanmarti","year":"1996","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/ard.52.6.418","article-title":"Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia","volume":"52","author":"Sanmarti","year":"1993","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.56.10.586","article-title":"Calcium pyrophosphate crystal deposition is not always \u2018wear and tear\u2019 or aging","volume":"56","author":"Wright","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2000.0087_RF50","first-page":"S160","article-title":"Probenecid therapy for refractory CPPD deposition disease","volume":"42","author":"Trostle","year":"1999","journal-title":"Arthritis and Rheumatism"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694200900871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694200900871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:52:26Z","timestamp":1555033946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694200900871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S1521694200900871"],"URL":"https:\/\/doi.org\/10.1053\/berh.2000.0087","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}